GSK and CureVac will together receive $740 million, as well as royalties on sales of COVID-19 vaccines in the US ...

The settlement ends US mRNA patent disputes involving COVID-19 and influenza vaccines, while positioning GSK for additional ...

British drugmaker GSK said on Monday that the U.S. Food and Drug Administration has accepted its application for priority ...

In exchange, Hengrui will receive $500m in upfront fees and will be eligible for approximately $12bn in development, ...

Germany's CureVac and Britain's GSK have settled a years-long patent dispute with Pfizer and its partner BioNTech over the ...

Find the latest GSK plc (GSK) stock quote, history, news and other vital information to help you with your stock trading and investing.

GSK Egypt posted non-consolidated net profits after tax of EGP 71.33 million in H1-25, an annual drop from EGP 99.54 million.

Long before Covid-19 turned the business world upside down and presented the health­care industry with one of its greatest challenges, GlaxoSmithKline (GSK) was transform­ing how teams work together.

This month‘s Pharm Exec feature, ” Building Belonging,“ looks at the efforts of big pharma companies to strengthen their diversity and inclusion (D&I) efforts in the face of the health and social ...

Mumbai: In a major relief for Thermo Fisher Scientific India Pvt. Ltd., the Income Tax Appellate Tribunal (ITAT), Mumbai "H" ...